Back to search

Article

Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults

2023-02-18

Abstract excerpt

Antibodies are used to estimate prevalence of past infection. However, T cell responses against SARS-CoV-2 may more accurately define prevalence because SARS-CoV-2-specific antibodies wane. In November-December 2021, we studied serological and cellular immune responses in residents of rural Kenya who had not experienced any respiratory symptom nor had contact with COVID-19 cases. Among participants we detected ant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bce40aa4-33e6-505f-9a31-5d37a291c4c0
DOI
10.1101/2023.02.17.23286075
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adultsDOI 10.1101/2023.02.17.23286075
Select a neighboring publication to make it the new centre.